William Kane
Keine laufenden Positionen mehr
Profil
William P.
Kane served as the Vice President-Commercial Operations at Keryx Biopharmaceuticals, Inc. He then worked as the Senior Vice President-US General Medicine at Allergan Ltd.
(Ireland) from 2017 to 2020.
In 2020, he became the Chief Commercial Officer & Executive VP at BioXcel Therapeutics, Inc. He later served as the Chief Commercial Officer at Karuna Therapeutics, Inc. in 2023.
Mr. Kane completed his undergraduate studies at Connecticut College.
He then pursued an MBA from The Wharton School of the University of Pennsylvania.
Ehemalige bekannte Positionen von William Kane
| Unternehmen | Position | Ende |
|---|---|---|
| KARA THER | Corporate Officer/Principal | 18.03.2024 |
| BIOXCEL THERAPEUTICS, INC. | Corporate Officer/Principal | 08.10.2021 |
| ALLERGAN PLC | Corporate Officer/Principal | 01.05.2020 |
| KERYX BIOPHARMACEUTICALS | Corporate Officer/Principal | - |
Ausbildung von William Kane
| Connecticut College | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOXCEL THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA. | Health Technology |
